Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Soleus Capital Master Fund, L.P. reported a 9.90% stake in Rigel Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Soleus Capital Master Fund, L.P. reported a 9.90% stake in Rigel Pharmaceuticals, Inc., 1,843,504 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 1,843,504
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 9.90% | 1,843,504 |
| Soleus Capital, LLC | 9.90% | 1,843,504 |
| Soleus Capital Group, LLC | 9.90% | 1,843,504 |
| Soleus Capital Management, L.P. | 9.90% | 1,843,504 |
| Soleus GP, LLC | 9.90% | 1,843,504 |
| Guy Levy | 9.90% | 1,843,504 |
Source
Related
- Rigel Pharmaceuticals, Inc.
- Soleus Capital Master Fund, L.P.
- Rigel Pharmaceuticals, Inc. shareholders
- Schedule 13G · Soleus Capital Master Fund, L.P. · May 7, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 5, 2025
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Feb 11, 2025
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026